PASG
Passage Bio (PASG)
$21
About Passage Bio (PASG)
Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Details
Daily high
$4.26
Daily low
$3.94
Price at open
$4.13
52 Week High
$20.00
52 Week Low
$3.94
Market cap
13.5M
Dividend yield
0.00%
Volume
112,480
Avg. volume
149,514
P/E ratio
-.29
Passage Bio News
Details
Daily high
$4.26
Daily low
$3.94
Price at open
$4.13
52 Week High
$20.00
52 Week Low
$3.94
Market cap
13.5M
Dividend yield
0.00%
Volume
112,480
Avg. volume
149,514
P/E ratio
-.29